Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: J Genet Couns. 2022 Jul 7;31(6):1330–1340. doi: 10.1002/jgc4.1607

Table 2: Averaged Scored Response (Mean +/− SD) to Likert Scale Questions by Different Groups of Participants.

(value 1=strongly disagree; value 5=strongly agree). One-Way ANOVA statistics with Tukey post-hoc analysis for comparison between the groups showed:

Question Practicing Genetic Counselors Genetic Counseling Students Practicing Physicians Medical Students Laboratory Scientists Degrees of freedom F-value p-value
 1. Everyone should receive ES at birth. 1.6 ± 0.6 , 1.6 ± 1.2 1.7 ± 0.9 2.8 ± 1.2 , , § 2.8 ± 1.1 4 7.202 0.000
 2. prenatal ES should never be used. 1.1 ± 0.3 1.5 ± 0.8 1.4 ± 0.7 1.5 ± 0.9 1.7 ± 1.3 4 0.929 0.451
 3. Invasive prenatal testing should be offered to every pregnant woman. 4.2 ± 1.1 4.4 ± 0.7 3.6 ± 1.4 3.3 ± 1.3 3.3 ± 0.9 4 2.221 0.074
 4. Prospective parents should be able to request prenatal ES without medical indication. 2.4 ± 1.1 2.6 ± 1.4 2.7 ± 1.5 3.6 ± 1.3 3.6 ± 1.2 4 3.077 0.020
 5. prenatal ES should be the first diagnostic genetic test ordered in the context of an abnormal mid-pregnancy ultrasound. 1.6 ± 0.8 , 1.9 ± 1.1 2.3 ± 1.2 2.6 ± 0.8 , 3.9 ± 1.1 , , §, 4 8.443 0.000
 6. prenatal ES should be the genetic test ordered in the context of an abnormal mid-pregnancy ultrasound BUT only after karyotyping + CMA fails to identify an underlying genetic etiology. 4.0 ± 1.1 3.6 ± 1.1 4.2 ± 0.8 4.1 ± 0.6 3.8 ± 1.3 4 0.806 0.525
 7. prenatal ES should be the first diagnostic genetic test ordered in the context of a positive combined first screen for trisomy 21. 1.0 ± 0.0 §, , 1.5 ± 0.8 , 2.3 ± 1.3 , , 3.2 ± 1.1 , , § 3.7 ± 1.1 , , § 4 15.669 0.000
 8. prenatal ES should always be used in the context of advanced maternal age (35 years +). 1.2 ± 0.4 , 1.4 ± 0.6 , 1.9 ± 1.1 2.6 ± 1.2 3.2 ± 1.2 , , § 4 8.936 0.000
 9. prenatal ES should be offered to every prospective mother in her first trimester. 1.6 ± 0.6 , 1.5 ± 0.8 1.8 ± 0.9 , 2.7 ± 1.6 , , § 3.1 ± 1.2 , , § 4 5.796 0.000
 10. prenatal ES should be offered to every prospective mother in her second trimester. 1.6 ± 0.6 , 1.7 ± 0.2 1.8 ± 1.0 2.7 ± 1.5 , § 3.0 ± 1.1 4 4.610 0.002
 11. ES should be performed on stillbirths. 2.8 ± 1.2 2.1 ± 1.4 3.4 ± 1.5 3.3 ± 1.3 3.8 ± 1.3 4 2.185 0.078

= significant difference compared to genetic counselors;

= significant difference compared to genetic counseling students;

§ = significant difference compared to practicing physicians.

¶ = significant difference compared to medical students.

= significant difference compared to laboratory scientists.

Significant difference is defined as a P value < 0.05. Between groups degrees of freedom, F values, and P values are listed. Abbreviations: ES, exome sequencing; CMA, chromosomal microarray analysis.